# Long‐term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add‐on therapy to metformin in patients with type 2 diabetes: 4‐year data

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/long-term-glycaemic-response-and-tolerability-of-dapagliflozin-versus-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stefano Del Prato,Michael A. Nauck,S. Durán‐García,Laura Maffei,Katja Rohwedder,A. Theuerkauf,Shamik Parikh |
| Citations | 233 |
| DOI | 10.1111/dom.12459 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2101329765 |
| PMID | 25735400 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Katja Rohwedder](https://scholariq.org/researchers/katja-rohwedder/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.